Novartis India Q2 Results Live : Novartis India declared their Q2 results on 25 October 2024, reporting a topline increase of 10.59% year-over-year. However, the company faced challenges as profit decreased by 13.81% in the same period.
In comparison to the previous quarter, Novartis experienced a decline in revenue by 5.62% and a significant drop in profit by 20.71%. This indicates potential headwinds the company may need to address moving forward.
Notably, the Selling, General & Administrative (SG&A) expenses saw a positive trend, declining by 5.97% quarter-over-quarter and by 3.17% year-over-year. This reduction could be a strategic move to enhance profitability amid rising costs.
The operating income reported a decrease of 25.79% from the previous quarter, although it did show an increase of 6.89% year-over-year. This mixed performance highlights the ongoing volatility in operational efficiency.
Earnings Per Share (EPS) for Q2 stood at ₹8.27, reflecting a decrease of 13.76% year-over-year, which may concern investors looking for consistent growth.
In terms of stock performance, Novartis India has delivered a -4.82% return over the last week, a modest 1.07% return over the past six months, and an impressive 36.7% year-to-date return, suggesting a mixed sentiment among investors.
As of now, Novartis India holds a market capitalization of ₹2609.94 crore, with a 52-week high of ₹1248 and a low of ₹599.95, indicating significant fluctuations in its stock price over the year.
Novartis India Financials
| Period | Q2 | Q1 | Q-o-Q Growth | Q2 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 87.1 | 92.29 | -5.62% | 78.76 | +10.59% |
| Selling/ General/ Admin Expenses Total | 5.2 | 5.53 | -5.97% | 5.37 | -3.17% |
| Depreciation/ Amortization | 0.58 | 0.55 | +5.45% | 0.65 | -10.77% |
| Total Operating Expense | 69.72 | 68.87 | +1.23% | 62.5 | +11.55% |
| Operating Income | 17.38 | 23.42 | -25.79% | 16.26 | +6.89% |
| Net Income Before Taxes | 27.56 | 33.68 | -18.17% | 32.43 | -15.02% |
| Net Income | 20.41 | 25.74 | -20.71% | 23.68 | -13.81% |
| Diluted Normalized EPS | 8.27 | 10.42 | -20.63% | 9.59 | -13.76% |
#Novartis #India #Results #Live #Profit #Falls #YOY #Company #Business #News
Novartis India Q2 result, Novartis India, Novartis India Q2, Novartis India Quarterly Result, Q2 Result
latest news today, news today, breaking news, latest news today, english news, internet news, top news, oxbig, oxbig news, oxbig news network, oxbig news today, news by oxbig, oxbig media, oxbig network, oxbig news media
HINDI NEWS
